Intocell

KOSDAQ · Healthcare · ₩255B

₩16,870-0.65%

Price

24,900원

16,870원

Jun 15, 26Sep 11, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

6/'26

Revenue₩760M+170.4%

Operating Income-₩2.2B+37.5%

Net Income-₩2.1B+48.3%

3/'26 vs prev quarter

Company Health

Market Cap₩255B

Operating Margin-279.0%

Cash on Hand106억원4.2% of market cap

Free Cash Flow-118억원-4.6% of market cap

Short Volume 7.8% · as of 26.09.11

Among 36 신약 개발 peers

LowMedianHigh

PSR81.0xmedian 31.7xPBR13.2xmedian 6.4xROE-48.0%median -31.6%